Research Summary
Juvéderm® HYDRATE is a new un-crosslinked hyaluronic acid (HA) injectable treatment containing mannitol. It comprises 13.5 mg/g of un-crosslinked hyaluronic acid along with 0.9% mannitol. This treatment is indicated for improving skin hydration and elasticity through multi-injection techniques into the dermal/epidermal junction and the superficial dermis. The purpose is to enhance skin tone and reduce the appearance of fine lines and wrinkles.
The inclusion of mannitol in the formulation helps reduce free radical degradation of the hyaluronic acid, thereby extending its longevity.
<Access the full report below>